Skip to search.
 FTSE 100 Down 0.29%

MannKind Corp. (MNKD)

-NasdaqGM
5.32 Down 0.26(4.57%) 2 Jul 21:00
Add to Portfolio
Prev Close:5.58
Open:5.55
Bid:5.25 x 100
Ask:5.39 x 100
1y Target Est:7.46
Beta:2.97
Next Earnings Date: 3-Aug-15MNKD Earnings announcement
Day's Range:5.25 - 5.58
52wk Range:3.46 - 10.26
Volume:7,320,457
Avg Vol (3m):7,876,950
Market Cap:2.18b
P/E (ttm):N/A
EPS (ttm):-0.45
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNKDDown 4.57%2.18b
LLYUp 1.52%91.22b
GSKUp 0.28%102.06b
NVODown 0.47%143.29b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.31
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback